Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for CGEM
| Stock Name | Cullinan Oncology LLC |
| Ticker | CGEM(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US2300311063 |
Show aggregate CGEM holdings
News associated with CGEM
- Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Average Rating of “Buy” by Brokerages
- Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) have been assigned an average recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the […] - 2025-08-28 02:56:53
- 5 Biotech Stocks To Watch Ahead Of Major Clinical Trial Data Readouts In September 2025
- (RTTNews) - September 2025 could be a make-or-break month for some biotech stocks, as the companies prepare to release critical clinical trial data. - 2025-08-27 06:40:47
- Morgan Stanley Has Lowered Expectations for Cullinan Therapeutics (NASDAQ:CGEM) Stock Price
- Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price target lowered by Morgan Stanley from $35.00 to $28.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Morgan Stanley’s price objective points to a potential upside of 269.39% from the stock’s current price. […] - 2025-08-20 02:46:46
- Exchange Traded Concepts LLC Has $107,000 Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
- Exchange Traded Concepts LLC raised its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 42.6% during the 1st quarter, HoldingsChannel reports. The fund owned 14,107 shares of the company’s stock after purchasing an additional 4,216 shares during the period. Exchange Traded Concepts LLC’s holdings in Cullinan Therapeutics were worth $107,000 as […] - 2025-06-25 04:57:01
- Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Sees Significant Decline in Short Interest
- Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 5,990,000 shares, a drop of 19.9% from the April 30th total of 7,480,000 shares. Currently, 16.7% of the company’s shares are short sold. Based on an […] - 2025-06-02 05:08:54
- Tower Research Capital LLC TRC Grows Stock Holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
- Tower Research Capital LLC TRC grew its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 411.3% during the 4th quarter, HoldingsChannel reports. The fund owned 8,800 shares of the company’s stock after buying an additional 7,079 shares during the period. Tower Research Capital LLC TRC’s holdings in Cullinan Therapeutics were worth […] - 2025-05-09 05:55:00
- Wells Fargo & Company MN Acquires 8,056 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
- Wells Fargo & Company MN lifted its holdings in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 47.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,864 shares of the company’s stock after acquiring an additional 8,056 […] - 2025-05-07 04:24:54
- Barclays PLC Sells 3,383 Shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
- Barclays PLC lowered its holdings in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 1.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 245,231 shares of the company’s stock after selling 3,383 shares during the period. Barclays PLC’s holdings in Cullinan […] - 2025-04-30 05:50:47
- Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Stock Position Decreased by Legal & General Group Plc
- Legal & General Group Plc decreased its position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 7.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 42,808 shares of the company’s stock after selling 3,649 shares during the quarter. Legal & General Group Plc’s holdings in Cullinan Therapeutics were worth $521,000 as of […] - 2025-04-30 04:52:47
- Brokerages Set Cullinan Therapeutics, Inc. (NASDAQ:CGEM) PT at $34.80
- Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) has been assigned an average recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have covered the stock in the […] - 2025-04-30 02:34:45
- 23,500 Shares in Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Purchased by ExodusPoint Capital Management LP
- ExodusPoint Capital Management LP bought a new stake in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 23,500 shares of the company’s stock, valued at approximately $286,000. Other hedge funds and other institutional investors also recently made changes […] - 2025-04-14 05:05:19
- Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Holdings Raised by American Century Companies Inc.
- American Century Companies Inc. raised its stake in shares of Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) by 11.0% during the 4th quarter, Holdings Channel reports. The institutional investor owned 100,721 shares of the company’s stock after buying an additional 10,010 shares during the period. American Century Companies Inc.’s holdings in Cullinan Therapeutics were worth […] - 2025-04-11 04:37:03
- Empirical Financial Services LLC d.b.a. Empirical Wealth Management Takes Position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM)
- Empirical Financial Services LLC d.b.a. Empirical Wealth Management bought a new position in Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 11,153 shares of the company’s stock, valued at approximately $136,000. Other large investors have […] - 2025-01-31 07:37:08
- Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Expected to Rise, HC Wainwright Analyst Says
- Cullinan Therapeutics (NASDAQ:CGEM – Get Free Report) had its price objective boosted by investment analysts at HC Wainwright from $28.00 to $33.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 200.55% from the stock’s […] - 2025-01-31 06:38:56
iShares MSCI World Small Cap UCITS ETF USD (Acc) CGEM holdings
| Date | Number of CGEM Shares Held | Base Market Value of CGEM Shares | Local Market Value of CGEM Shares | Change in CGEM Shares Held | Change in CGEM Base Value | Current Price per CGEM Share Held | Previous Price per CGEM Share Held |
|---|
| 2025-10-15 (Wednesday) | 28,928 | USD 249,649 | USD 249,649 | | | | |
| 2025-10-10 (Friday) | 28,724 | USD 212,558 | USD 212,558 | | | | |
| 2025-10-08 (Wednesday) | 28,724 | USD 185,270 | USD 185,270 | | | | |
| 2025-10-07 (Tuesday) | 28,724 | USD 169,184 | USD 169,184 | 136 | USD 2,230 | USD 5.88999 | USD 5.84 |
| 2025-10-06 (Monday) | 28,588 | USD 166,954 | USD 166,954 | 0 | USD -1,715 | USD 5.84 | USD 5.89999 |
| 2025-10-03 (Friday) | 28,588 | USD 168,669 | USD 168,669 | 0 | USD 4,288 | USD 5.89999 | USD 5.75 |
| 2025-10-02 (Thursday) | 28,588 | USD 164,381 | USD 164,381 | 0 | USD -7,147 | USD 5.75 | USD 6 |
| 2025-10-01 (Wednesday) | 28,588 | USD 171,528 | USD 171,528 | 0 | USD 2,001 | USD 6 | USD 5.93001 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of CGEM by Blackrock for IE00BF4RFH31
Show aggregate share trades of CGEM| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-07 | BUY | 136 | | | 5.890* | | 9.99 |
| 2025-09-08 | SELL | -272 | | | 6.840* | | 10.20 Profit of 2,773 on sale |
| 2025-08-15 | BUY | 136 | | | 7.660* | | 10.21 |
| 2025-07-14 | BUY | 272 | | | 7.870* | | 10.32 |
| 2025-06-30 | BUY | 272 | | | 7.530* | | 10.44 |
| 2025-06-25 | BUY | 402 | | | 7.920* | | 10.47 |
| 2025-06-20 | SELL | -67 | | | 7.670* | | 10.53 Profit of 705 on sale |
| 2025-06-12 | SELL | -544 | | | 8.950* | | 10.61 Profit of 5,773 on sale |
| 2025-06-02 | BUY | 204 | | | 8.750* | | 10.71 |
| 2025-05-28 | BUY | 136 | | | 7.840* | | 10.76 |
| 2025-05-14 | BUY | 67 | | | 7.130* | | 11.01 |
| 2025-05-13 | BUY | 134 | | | 7.620* | | 11.04 |
| 2025-05-07 | BUY | 201 | | | 7.700* | | 11.15 |
| 2025-04-28 | BUY | 67 | | | 7.755* | | 11.33 |
| 2025-04-16 | BUY | 871 | | | 7.610* | | 11.58 |
| 2025-04-14 | BUY | 134 | | | 7.740* | | 11.65 |
| 2025-04-08 | SELL | -134 | | | 7.320* | | 11.82 Profit of 1,584 on sale |
| 2025-04-04 | SELL | -134 | | | 7.410* | | 11.91 Profit of 1,596 on sale |
| 2025-03-28 | BUY | 670 | | | 8.020* | | 12.09 |
| 2025-03-12 | SELL | -134 | | | 9.080* | | 12.60 Profit of 1,688 on sale |
| 2025-03-04 | SELL | -134 | | | 8.130* | | 12.87 Profit of 1,725 on sale |
| 2025-02-26 | SELL | -268 | | | 8.450* | | 13.12 Profit of 3,517 on sale |
| 2025-02-13 | BUY | 67 | | | 9.590* | | 13.68 |
| 2025-02-12 | BUY | 268 | | | 9.890* | | 13.74 |
| 2025-01-27 | BUY | 67 | | | 10.300* | | 14.55 |
| 2025-01-23 | BUY | 67 | | | 10.560* | | 14.72 |
| 2024-12-09 | BUY | 2,376 | | | 12.700* | | 15.00 |
| 2024-12-04 | BUY | 132 | | | 12.960* | | 15.16 |
| 2024-12-03 | BUY | 198 | | | 12.800* | | 15.22 |
| 2024-11-19 | BUY | 396 | | | 13.100* | | 16.01 |
| 2024-11-18 | BUY | 132 | | | 13.450* | | 16.10 |
| 2024-11-12 | BUY | 256 | | | 16.020* | | 16.10 |
| 2024-11-11 | BUY | 64 | | | 17.270* | | 16.01 |
| 2024-11-11 | BUY | 64 | | | 17.270* | | 16.01 |
| 2024-11-07 | BUY | 315 | | | 15.580* | | 16.05 |
| 2024-11-07 | BUY | 315 | | | 15.580* | | 16.05 |
| 2024-10-23 | BUY | 124 | | | 15.610* | | 16.08 |
| 2024-10-23 | BUY | 124 | | | 15.610* | | 16.08 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of CGEM
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 91,713 | 0 | 453,137 | 20.2% |
| 2025-09-18 | 29,909 | 64 | 374,322 | 8.0% |
| 2025-09-17 | 29,113 | 561 | 152,081 | 19.1% |
| 2025-09-16 | 41,765 | 2 | 156,366 | 26.7% |
| 2025-09-15 | 69,037 | 556 | 213,450 | 32.3% |
| 2025-09-12 | 76,084 | 0 | 383,502 | 19.8% |
| 2025-09-11 | 66,615 | 867 | 581,520 | 11.5% |
| 2025-09-10 | 55,097 | 0 | 308,725 | 17.8% |
| 2025-09-09 | 106,491 | 0 | 278,733 | 38.2% |
| 2025-09-08 | 44,979 | 0 | 172,182 | 26.1% |
| 2025-09-05 | 92,584 | 2,960 | 314,975 | 29.4% |
| 2025-09-04 | 218,977 | 13,252 | 745,971 | 29.4% |
| 2025-09-03 | 59,535 | 0 | 162,544 | 36.6% |
| 2025-09-02 | 30,215 | 0 | 107,256 | 28.2% |
| 2025-08-29 | 28,955 | 0 | 102,690 | 28.2% |
| 2025-08-28 | 39,008 | 0 | 89,895 | 43.4% |
| 2025-08-27 | 50,544 | 0 | 153,481 | 32.9% |
| 2025-08-26 | 38,684 | 3 | 378,657 | 10.2% |
| 2025-08-25 | 17,620 | 0 | 58,531 | 30.1% |
| 2025-08-22 | 73,100 | 0 | 173,435 | 42.1% |
| 2025-08-21 | 27,559 | 0 | 85,312 | 32.3% |
| 2025-08-20 | 37,739 | 0 | 91,418 | 41.3% |
| 2025-08-19 | 37,960 | 0 | 83,526 | 45.4% |
| 2025-08-18 | 77,212 | 0 | 180,135 | 42.9% |
| 2025-08-15 | 37,996 | 0 | 114,067 | 33.3% |
| 2025-08-14 | 15,179 | 0 | 186,706 | 8.1% |
| 2025-08-13 | 25,903 | 0 | 130,511 | 19.8% |
| 2025-08-12 | 44,973 | 0 | 119,053 | 37.8% |
| 2025-08-11 | 41,962 | 128 | 103,183 | 40.7% |
| 2025-08-08 | 67,304 | 2,573 | 153,714 | 43.8% |
| 2025-08-07 | 80,102 | 176 | 173,936 | 46.1% |
| 2025-08-06 | 21,373 | 0 | 51,516 | 41.5% |
| 2025-08-05 | 22,741 | 0 | 58,650 | 38.8% |
| 2025-08-04 | 26,114 | 0 | 93,276 | 28.0% |
| 2025-08-01 | 38,240 | 579 | 76,874 | 49.7% |
| 2025-07-31 | 35,027 | 58 | 68,864 | 50.9% |
| 2025-07-30 | 80,500 | 0 | 739,899 | 10.9% |
| 2025-07-29 | 58,393 | 9 | 130,459 | 44.8% |
| 2025-07-28 | 27,557 | 0 | 46,548 | 59.2% |
| 2025-07-25 | 21,736 | 176 | 36,209 | 60.0% |
| 2025-07-24 | 54,730 | 18 | 130,095 | 42.1% |
| 2025-07-23 | 77,967 | 0 | 133,955 | 58.2% |
| 2025-07-22 | 49,802 | 0 | 89,671 | 55.5% |
| 2025-07-21 | 27,480 | 0 | 40,112 | 68.5% |
| 2025-07-18 | 29,606 | 0 | 50,251 | 58.9% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.